Omega Therapeutics SG&A Expense (TTM) Insights

Omega Therapeutics Inc (OMGA)

2.07 -0.18 (-8.00%) USD | NASDAQ | Jul 02, 16:00

2.07 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	27.63M
December 31, 2023	26.47M
September 30, 2023	27.52M
June 30, 2023	24.85M
March 31, 2023	24.85M
December 31, 2022	24.01M
September 30, 2022	22.50M

Date	Value
June 30, 2022	21.76M
March 31, 2022	19.19M
December 31, 2021	16.53M
September 30, 2021	12.66M
June 30, 2021	10.24M
March 31, 2021	7.616M
December 31, 2020	6.236M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

6.236M

Minimum

Dec 2020

27.63M

Maximum

Mar 2024

19.43M

Average

22.13M

Median

SG&A Expense (TTM) Benchmarks